Document is current
Any future updates will be listed below
-
Authors
Mendes, Luís https://orcid.org/0000-0002-3432-3604
Rocha, Ana https://orcid.org/0009-0000-9014-0362
Lopes, Marta https://orcid.org/0000-0002-5403-8499
Almeida, Ana https://orcid.org/0000-0002-9873-8729
Duarte, Nicole https://orcid.org/0000-0001-5645-0957
Reste-Ferreira, Débora https://orcid.org/0000-0002-8769-1355
Martinho, António https://orcid.org/0000-0001-8447-9255
Pereira, Pedro
Marques, Inês https://orcid.org/0000-0001-9170-6997
Lobo, Conceição https://orcid.org/0000-0001-5831-7711
Cunha-Vaz, José https://orcid.org/0000-0002-0947-9850
-
Funding
Funding for this research was provided by:
NA (This work was supported by AIBILI, by NextGenerationEU (PRR - Financiamento Base - Centros de Tecnologia e Inovação - Investimento RE-C05-i02 - Missão Interface nº 03/C05-i02/2022).)
- License Information
-
More Information
Article History
Received: 9 April 2025
Accepted: 23 May 2025
First Online: 1 July 2025
Declarations
:
: Luís Mendes, Ana Rocha, Marta Lopes, Ana Almeida, Nicole Duarte, Débora Reste-Ferreira, António Martinho, Pedro Pereira, Inês Marques, and Conceição Lobo declare there are no conflicts of interest. Pedro Pereira was a Retmarker employee. José Cunha-Vaz reports grants from Bayer, Boehringer Ingelheim and Carl Zeiss Meditec and is a consultant for Alimera Sciences, Bayer, Boehringer Ingelheim, Carl Zeiss Meditec and Roche. José Cunha-Vaz is an Editorial Board member of Ophthalmology and Therapy. José Cunha-Vaz was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: The tenets of the Declaration of Helsinki were followed, and approval was obtained from the AIBILI Ethics Committee for Health with the number CEC/009/17- EYEMARKER. Written informed consent was obtained by each participant agreeing to participate in the study.
